Ischemic Reperfusion Myocardial Injury ; Its Mechanism and Prevention.
缺血再灌注心肌损伤;
基本信息
- 批准号:61570422
- 负责人:
- 金额:$ 1.47万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for General Scientific Research (C)
- 财政年份:1986
- 资助国家:日本
- 起止时间:1986 至 1988
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The mechanism and the prevention of reperfusion myocardial injuries were investigated in the following two sets of studies:1. Mechanism of a protective effect of alloprinol(AL) on hypoxia-reoxygenation was investigated in isolated rat hearts. When AL(100 M) was added to the perfusate during prehypoxic, hypoxic and reoxy-genation periods, hearts continued to beat, though weak, during hypoxia, and tension development recover 18% of control level at 30 min of reoxygenation. Without AL, the tension development was abolished within 20 min of hypoxic perfusion, and not recovered by reoxygenation. During hypoxia, tissue ATP of AL treated hearts was much higher than that of non-treated groups. AL markedly accelerated the glycolysis during the early hypoxia. AL prevented the CPK release, reduction of Na, KATPase activity, and malondialdehyde formation during reoxygenation. Thus, in addition to the well-known inhibitory effect on oxygen radicals mediated injury, AL protects hypoxic-reoxypenated hearts by maintaining ATP at markdly high levels during hypoxia.2. The relation between Ca overload and myocardial injury in Ca-paradox was examined in naonatal rat hearts loaded with fura-2. In hearts from rats under 8 days of age, (Ca)i decreased and reached a plateau level during Ca-free perfusion, and upon Ca-repletion after 5 min, (Ca)i returned to the normal control level. Neither Ca overload nor CPK release was observed. In hearts from 9- to 14- day old rats, upon Ca-repletion, (Ca)i increased and Ca overload was observed. However, 80% of the hearts maintained contractility and there was little release of CPK. Thus, in addition to Ca overload, the maturity of sarcolemmal functions and structure is a pre-requisite for the full development of Ca-paradox injury of hearts.
通过以下两组研究探讨了再灌注心肌损伤的机制和预防措施:研究了别丙醇(AL)对离体大鼠心脏缺氧再氧化保护作用的机制。在缺氧前、缺氧和复氧期间向灌注液中加入AL(100 M),心脏在缺氧期间继续搏动,虽然微弱,在复氧30分钟时,张力发展恢复到对照水平的18%。无AL时,低氧灌注20 min内张力发展消失,再氧不能恢复。缺氧时,AL处理组心脏组织ATP明显高于未处理组。早期缺氧时,AL明显加速糖酵解。AL阻止CPK的释放、Na的减少、KATPase活性和再氧化过程中丙二醛的形成。因此,除了众所周知的对氧自由基介导的损伤的抑制作用外,AL还通过在缺氧时将ATP维持在显著的高水平来保护缺氧再氧心脏。在载fura-2的新生大鼠心脏中研究钙超载与心肌损伤的关系。在8日龄大鼠的心脏中,(Ca)i在无Ca灌注期间下降并达到平台水平,5min后Ca充满后(Ca)i恢复到正常对照水平。没有观察到Ca超载和CPK释放。在9 ~ 14日龄大鼠心脏中,钙补充后,(Ca)i增加,出现钙超载。然而,80%的心脏保持收缩力,CPK几乎没有释放。因此,除了钙超载外,肌层功能和结构的成熟是心脏钙悖论损伤充分发展的先决条件。
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KANAIDE Hideo其他文献
KANAIDE Hideo的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KANAIDE Hideo', 18)}}的其他基金
Development of a system for the continuous and simultaneous measurement of vascular intracellular signalings and metabolism
开发连续同步测量血管细胞内信号传导和代谢的系统
- 批准号:
13557067 - 财政年份:2001
- 资助金额:
$ 1.47万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Molecular mechanisms of vasospasm : Intracellular signaling network underlying the Ca^<2+> of smooth muscle cells.
血管痉挛的分子机制:平滑肌细胞Ca^2 的细胞内信号网络。
- 批准号:
13470149 - 财政年份:2001
- 资助金额:
$ 1.47万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of the optical system for continuous and multi-factorial monitoring of the intracellular signaling network in endothelial and smooth muscle cells in vascular strips.
开发光学系统,用于连续和多因素监测血管条内皮细胞和平滑肌细胞的细胞内信号网络。
- 批准号:
10557072 - 财政年份:1998
- 资助金额:
$ 1.47万 - 项目类别:
Grant-in-Aid for Scientific Research (B).
Studies on molecular cell biology of the inhibition of coronary vasoconstriction and intimal thickening.
抑制冠状血管收缩和内膜增厚的分子细胞生物学研究。
- 批准号:
07407022 - 财政年份:1995
- 资助金额:
$ 1.47万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
TO DEVELOP A NEW SYSTEM TO CONTIMUOUSLY MONITOR THE FUNCTIONS AT THE CELLULAR AND MOLECULAR LEVELS OF THE VASCULAR ENDOTHELIAL AND SMOOTH MUSCLE CELLS IN VIVO.
开发一种新系统,在体内连续监测血管内皮细胞和平滑肌细胞的细胞和分子水平的功能。
- 批准号:
06557045 - 财政年份:1994
- 资助金额:
$ 1.47万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
THE PATHOGENESIS OF AN INCREASE IN VASCULAR TONUS : THE DEVELOPMENT OF NEW VASODILATORS.
血管紧张度增加的发病机制:新血管扩张剂的开发。
- 批准号:
04454268 - 财政年份:1992
- 资助金额:
$ 1.47万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
THE DEVELOPMENT AND THE CLINICAL APPLICATION OF AN OPTICAL SYSTEM FOR THE SIMULTANEOUS DETERMINATION OF METABOLIC AND FUNCTIONAL CHANGES IN THE HEART AND BLOOD VESSELS.
用于同时测定心脏和血管代谢和功能变化的光学系统的开发和临床应用。
- 批准号:
03557043 - 财政年份:1991
- 资助金额:
$ 1.47万 - 项目类别:
Grant-in-Aid for Developmental Scientific Research (B)
CELLULAR BIOLOGY OF ANTIANGINAL AGENTS ; DEVELOPMENT AND EVALUATION OF NEW DRUGS.
抗心绞痛药物的细胞生物学;
- 批准号:
01480250 - 财政年份:1989
- 资助金额:
$ 1.47万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
相似海外基金
A novel treatment for REBOA complications: Hydrogen gas inhalation therapy to alleviate oxidative stress due to ischemia-reperfusion injury
REBOA并发症的新型治疗方法:氢气吸入疗法减轻缺血再灌注损伤引起的氧化应激
- 批准号:
23K21458 - 财政年份:2024
- 资助金额:
$ 1.47万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of a customed designed oxygenation system combined with novel therapy to treat reperfusion injury following Neurovascular Thrombectomy.
开发定制设计的氧合系统与新疗法相结合,治疗神经血管血栓切除术后的再灌注损伤。
- 批准号:
10057485 - 财政年份:2023
- 资助金额:
$ 1.47万 - 项目类别:
Collaborative R&D
Development ofsynthetic heparin to protect liver graft from ischemia reperfusion injury duringtransplantation
开发合成肝素以保护移植肝免受移植过程中的缺血再灌注损伤
- 批准号:
10759102 - 财政年份:2023
- 资助金额:
$ 1.47万 - 项目类别:
The Role of Neutrophils in Ischemia/Reperfusion Injury following Acute Stroke
中性粒细胞在急性中风后缺血/再灌注损伤中的作用
- 批准号:
10606952 - 财政年份:2023
- 资助金额:
$ 1.47万 - 项目类别:
Zinc Protection Against Ischemia-Reperfusion Injury in Heart
锌可预防心脏缺血再灌注损伤
- 批准号:
10652915 - 财政年份:2023
- 资助金额:
$ 1.47万 - 项目类别:
Non-invasive imaging of reactive oxygen species in reperfusion injury myocardial infarction
再灌注损伤心肌梗死中活性氧的无创成像
- 批准号:
10716836 - 财政年份:2023
- 资助金额:
$ 1.47万 - 项目类别:
Ischemia/Reperfusion injury and Myocardial edema
缺血/再灌注损伤和心肌水肿
- 批准号:
10718260 - 财政年份:2023
- 资助金额:
$ 1.47万 - 项目类别:
Role of Gasdermin D/E in intestinal ischemia-reperfusion injury
Gasdermin D/E 在肠缺血再灌注损伤中的作用
- 批准号:
23K15529 - 财政年份:2023
- 资助金额:
$ 1.47万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
STTR Phase I: Cardiotropic Atorvastatin Liposomes for Myocardial Reperfusion Injury
STTR 第一期:用于治疗心肌再灌注损伤的强心阿托伐他汀脂质体
- 批准号:
2300933 - 财政年份:2023
- 资助金额:
$ 1.47万 - 项目类别:
Standard Grant














{{item.name}}会员




